Steris | STE - Equity Capital And Reserves



Steris reported $6.96B in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
3M USD 4.29B 174M Jun/2025
Avanos Medical USD 776.3M 63.1M Jun/2025
Baxter International USD 7.05B 90M Mar/2025
Becton, Dickinson and Co. USD 25.47B 231M Jun/2025
Boston Scientific USD 22.21B 443M Mar/2025
CONMED USD 1B 25.23M Jun/2025
Cooper Companies USD 8.35B 64.9M Jul/2025
Dexcom USD 2.57B 306.5M Jun/2025
Ecolab USD 9.32B 444.5M Jun/2025
Edwards Lifesciences USD 10.19B 193.2M Mar/2025
Fortive USD 10.39B 152.8M Jun/2025
Getinge SEK 33.01B 2.75B Dec/2024
Globus Medical USD 4.3B 207.61M Jun/2025
Haemonetics USD 882.3M 61.46M Jun/2025
Hologic USD 4.84B 223.8M Jun/2025
Idexx Laboratories USD -4410277000 5.86B Jun/2025
Insulet USD 1.46B 132.2M Jun/2025
Integra LifeSciences USD 1.04B 485.48M Jun/2025
Intuitive Surgical USD 17.95B 745.4M Jun/2025
J&J USD 78.11B 6.62B Mar/2025
Masimo USD 1.04B 96.4M Jun/2025
Olympus JPY 732.65B 19.08B Jun/2025
Owens Minor USD 570.98M 5.75M Mar/2025
ResMed USD 5.97B 421.73M Jun/2025
Steris USD 6.96B 341.24M Jun/2025
Stryker USD 21.19B 261M Jun/2025
Tandem Diabetes Care USD 133.28M 22.01M Jun/2025
Teleflex USD 4.24B 147.7M Jun/2025
Thermo Fisher Scientific USD 49.36B 227M Mar/2025
Zimmer Biomet Holdings USD 12.53B 130.5M Jun/2025